ABSTRACT
Objective: to know the results of autologous blood injection in lateral epicondylitis. Out Patient department of Peshawar Institute of Medical Sciences, from March 2013 to December 2013
Material and Method: it is a prospective descriptive study conducted on 66 patients with lateral epicondyHt1s, fluffing the inclusion criteria presenting in DASH [Disability of the Arm, Shoulder and Hand] score was used as primary outcome measure and Thomsen provocative test to elicit pain and Nirschl score to evaluate pain function as secondary outcome. VAS score was used to measure pain. 2ml of autologous venous blood mixed with 1 ml of lignocaine 2% solution and injected by introducing the needle into lateral epicondyle of humorous at site which is most tender by peppering technique. Patients were followed up at 2 weeks, 6 weeks, 12 weeks and 24 weeks interval. Patient DASH score, VAS pain score and Nirschl score was recorded before autologous injection and at 12 and 24 weeks post injection. P-value of< 0.05 deemed to indicate statistical significance and was calculated where applicable
Results: mean age of the patients was 39.68 years +12.77. 32 of these patients were females And 34 were males. Dominant elbow was involved in 42 patients. Mean duration of symptoms was 8.9+3.2 months. During follow up 10 patients were lost [6 females and 4 males]. DASH score of patients improved from 86 to 64 at 12 weeks and to 49 at 24 weeks [P value <0.0001]. Mean VAS improved from 7 .63 to 3.89 and 1. 77 respectively at 12 and 24 week follow up [P value <0.0001]. Nirschl score of the patients receiving autologous blood injection improved to 3.69 and 1.66 at 12 and 24 weeks: follow up respectively from 5. 8 score of pre-autologous blood injection [P value <0.0001]
Conclusion: autologous blood injection has shown improvement in pain and physical activity and provide acceptable short to long term results